questionsmedicales.fr
Acides aminés, peptides et protéines
Protéines
Protéines et peptides de signalisation intracellulaire
Protein-Serine-Threonine Kinases
Cyclic Nucleotide-Regulated Protein Kinases
Cyclic GMP-Dependent Protein Kinases
Cyclic GMP-Dependent Protein Kinases : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Cyclic GMP-Dependent Protein Kinases : Questions médicales les plus fréquentes",
"headline": "Cyclic GMP-Dependent Protein Kinases : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Cyclic GMP-Dependent Protein Kinases : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-11",
"dateModified": "2025-04-06",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Cyclic GMP-Dependent Protein Kinases"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Cyclic Nucleotide-Regulated Protein Kinases",
"url": "https://questionsmedicales.fr/mesh/D017867",
"about": {
"@type": "MedicalCondition",
"name": "Cyclic Nucleotide-Regulated Protein Kinases",
"code": {
"@type": "MedicalCode",
"code": "D017867",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.563.150"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Cyclic GMP-dependent protein kinase type I",
"alternateName": "Cyclic GMP-Dependent Protein Kinase Type I",
"url": "https://questionsmedicales.fr/mesh/D062965",
"about": {
"@type": "MedicalCondition",
"name": "Cyclic GMP-dependent protein kinase type I",
"code": {
"@type": "MedicalCode",
"code": "D062965",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.563.150.150.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Cyclic GMP-dependent protein kinase type II",
"alternateName": "Cyclic GMP-Dependent Protein Kinase Type II",
"url": "https://questionsmedicales.fr/mesh/D062967",
"about": {
"@type": "MedicalCondition",
"name": "Cyclic GMP-dependent protein kinase type II",
"code": {
"@type": "MedicalCode",
"code": "D062967",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.563.150.150.750"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Cyclic GMP-Dependent Protein Kinases",
"alternateName": "Cyclic GMP-Dependent Protein Kinases",
"code": {
"@type": "MedicalCode",
"code": "D017869",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Fengyang Li",
"url": "https://questionsmedicales.fr/author/Fengyang%20Li",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Ute Römling",
"url": "https://questionsmedicales.fr/author/Ute%20R%C3%B6mling",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Stepan Gambaryan",
"url": "https://questionsmedicales.fr/author/Stepan%20Gambaryan",
"affiliation": {
"@type": "Organization",
"name": "Sechenov Institute of Evolutionary Physiology and Biochemistry of the Russian Academy of Sciences, Saint Petersburg 194223, Russia."
}
},
{
"@type": "Person",
"name": "Roshni R Kharadi",
"url": "https://questionsmedicales.fr/author/Roshni%20R%20Kharadi",
"affiliation": {
"@type": "Organization",
"name": "Department of Plant, Soil and Microbial Sciences, Michigan State University, East Lansing, Michigan, USA."
}
},
{
"@type": "Person",
"name": "George W Sundin",
"url": "https://questionsmedicales.fr/author/George%20W%20Sundin",
"affiliation": {
"@type": "Organization",
"name": "Department of Plant, Soil and Microbial Sciences, Michigan State University, East Lansing, Michigan, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Update on the Corneal Dystrophies-Genetic Testing and Therapy.",
"datePublished": "2022-07-04",
"url": "https://questionsmedicales.fr/article/36219210",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/ICO.0000000000002857"
}
},
{
"@type": "ScholarlyArticle",
"name": "Motivations and expectations of parents seeking genetic testing for their children with ocular genetic disease.",
"datePublished": "2023-05-12",
"url": "https://questionsmedicales.fr/article/37170870",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/13816810.2023.2209170"
}
},
{
"@type": "ScholarlyArticle",
"name": "Isolated frontosphenoidal craniosynostosis: An argument for genetic testing.",
"datePublished": "2023-07-08",
"url": "https://questionsmedicales.fr/article/37421219",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/ajmg.a.63348"
}
},
{
"@type": "ScholarlyArticle",
"name": "Genetic Testing for Familial Hypercholesterolemia in Clinical Practice.",
"datePublished": "2023-04-15",
"url": "https://questionsmedicales.fr/article/37060538",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s11883-023-01094-2"
}
},
{
"@type": "ScholarlyArticle",
"name": "Preimplantation genetic testing for familial amyloid polyneuropathy.",
"datePublished": "2022-11-19",
"url": "https://questionsmedicales.fr/article/36401333",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12978-022-01491-x"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Protéines et peptides de signalisation intracellulaire",
"item": "https://questionsmedicales.fr/mesh/D047908"
},
{
"@type": "ListItem",
"position": 5,
"name": "Protein-Serine-Threonine Kinases",
"item": "https://questionsmedicales.fr/mesh/D017346"
},
{
"@type": "ListItem",
"position": 6,
"name": "Cyclic Nucleotide-Regulated Protein Kinases",
"item": "https://questionsmedicales.fr/mesh/D017867"
},
{
"@type": "ListItem",
"position": 7,
"name": "Cyclic GMP-Dependent Protein Kinases",
"item": "https://questionsmedicales.fr/mesh/D017869"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Cyclic GMP-Dependent Protein Kinases - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Cyclic GMP-Dependent Protein Kinases",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-18",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Cyclic GMP-Dependent Protein Kinases",
"description": "Comment diagnostiquer une dysfonction des kinases cGMP ?\nQuels tests sont utilisés pour mesurer le cGMP ?\nQuels symptômes indiquent un problème avec les kinases cGMP ?\nLes tests génétiques sont-ils utiles pour les kinases cGMP ?\nComment évaluer l'activité des kinases cGMP ?",
"url": "https://questionsmedicales.fr/mesh/D017869?mesh_terms=Genetic+Testing&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Cyclic GMP-Dependent Protein Kinases",
"description": "Quels sont les symptômes d'une déficience en kinases cGMP ?\nLes troubles neurologiques sont-ils liés aux kinases cGMP ?\nComment les kinases cGMP affectent-elles la fonction cardiaque ?\nY a-t-il des symptômes spécifiques aux maladies liées aux kinases cGMP ?\nLes troubles de l'humeur peuvent-ils être liés aux kinases cGMP ?",
"url": "https://questionsmedicales.fr/mesh/D017869?mesh_terms=Genetic+Testing&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Cyclic GMP-Dependent Protein Kinases",
"description": "Comment prévenir les troubles liés aux kinases cGMP ?\nL'alimentation influence-t-elle les kinases cGMP ?\nLe stress a-t-il un impact sur les kinases cGMP ?\nLes examens réguliers sont-ils importants ?\nL'exercice physique aide-t-il à la prévention ?",
"url": "https://questionsmedicales.fr/mesh/D017869?mesh_terms=Genetic+Testing&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Cyclic GMP-Dependent Protein Kinases",
"description": "Quels traitements ciblent les kinases cGMP ?\nLes médicaments augmentant le cGMP sont-ils efficaces ?\nComment les thérapies géniques peuvent-elles aider ?\nY a-t-il des traitements naturels pour les dysfonctionnements cGMP ?\nLes changements de mode de vie peuvent-ils aider ?",
"url": "https://questionsmedicales.fr/mesh/D017869?mesh_terms=Genetic+Testing&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Cyclic GMP-Dependent Protein Kinases",
"description": "Quelles complications peuvent survenir avec des dysfonctionnements cGMP ?\nLes troubles de la coagulation sont-ils liés aux kinases cGMP ?\nY a-t-il des risques de cancer associés aux kinases cGMP ?\nLes maladies rénales peuvent-elles être influencées par cGMP ?\nLes troubles respiratoires sont-ils liés aux kinases cGMP ?",
"url": "https://questionsmedicales.fr/mesh/D017869?mesh_terms=Genetic+Testing&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Cyclic GMP-Dependent Protein Kinases",
"description": "Quels sont les facteurs de risque pour les dysfonctionnements cGMP ?\nL'âge influence-t-il la fonction des kinases cGMP ?\nLe mode de vie sédentaire est-il un facteur de risque ?\nLe stress chronique est-il un facteur de risque ?\nLes antécédents familiaux jouent-ils un rôle ?",
"url": "https://questionsmedicales.fr/mesh/D017869?mesh_terms=Genetic+Testing&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une dysfonction des kinases cGMP ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests biochimiques et des analyses génétiques peuvent être utilisés pour évaluer la fonction des kinases cGMP."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour mesurer le cGMP ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des dosages immunologiques et des tests enzymatiques peuvent mesurer les niveaux de cGMP dans les tissus."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un problème avec les kinases cGMP ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes variés comme des troubles cardiovasculaires ou neurologiques peuvent indiquer un dysfonctionnement."
}
},
{
"@type": "Question",
"name": "Les tests génétiques sont-ils utiles pour les kinases cGMP ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les tests génétiques peuvent identifier des mutations affectant les kinases cGMP."
}
},
{
"@type": "Question",
"name": "Comment évaluer l'activité des kinases cGMP ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'activité peut être évaluée par des essais enzymatiques spécifiques in vitro."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une déficience en kinases cGMP ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent inclure des troubles de la circulation sanguine et des problèmes de vision."
}
},
{
"@type": "Question",
"name": "Les troubles neurologiques sont-ils liés aux kinases cGMP ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anomalies dans les kinases cGMP peuvent contribuer à des troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Comment les kinases cGMP affectent-elles la fonction cardiaque ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles régulent la relaxation et la contraction cardiaque, influençant la pression artérielle."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes spécifiques aux maladies liées aux kinases cGMP ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes spécifiques peuvent inclure des douleurs thoraciques et des palpitations."
}
},
{
"@type": "Question",
"name": "Les troubles de l'humeur peuvent-ils être liés aux kinases cGMP ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des études suggèrent un lien entre les kinases cGMP et la régulation de l'humeur."
}
},
{
"@type": "Question",
"name": "Comment prévenir les troubles liés aux kinases cGMP ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Maintenir un mode de vie sain et surveiller les facteurs de risque cardiovasculaires aide à prévenir."
}
},
{
"@type": "Question",
"name": "L'alimentation influence-t-elle les kinases cGMP ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation riche en antioxydants peut soutenir la fonction des kinases cGMP."
}
},
{
"@type": "Question",
"name": "Le stress a-t-il un impact sur les kinases cGMP ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut affecter la signalisation cGMP et la santé cardiovasculaire."
}
},
{
"@type": "Question",
"name": "Les examens réguliers sont-ils importants ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des examens réguliers peuvent aider à détecter précocement des dysfonctionnements cGMP."
}
},
{
"@type": "Question",
"name": "L'exercice physique aide-t-il à la prévention ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier peut améliorer la signalisation cGMP et la santé globale."
}
},
{
"@type": "Question",
"name": "Quels traitements ciblent les kinases cGMP ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des inhibiteurs spécifiques et des modulateurs de cGMP sont utilisés pour traiter certaines conditions."
}
},
{
"@type": "Question",
"name": "Les médicaments augmentant le cGMP sont-ils efficaces ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des médicaments comme les nitrates et les inhibiteurs de la phosphodiestérase peuvent être efficaces."
}
},
{
"@type": "Question",
"name": "Comment les thérapies géniques peuvent-elles aider ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les thérapies géniques peuvent corriger des mutations dans les gènes des kinases cGMP."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements naturels pour les dysfonctionnements cGMP ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines plantes médicinales peuvent avoir des effets bénéfiques sur la signalisation cGMP."
}
},
{
"@type": "Question",
"name": "Les changements de mode de vie peuvent-ils aider ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation saine et l'exercice peuvent améliorer la fonction des kinases cGMP."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec des dysfonctionnements cGMP ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications peuvent inclure des maladies cardiovasculaires et des troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Les troubles de la coagulation sont-ils liés aux kinases cGMP ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anomalies dans les kinases cGMP peuvent affecter la coagulation sanguine."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques de cancer associés aux kinases cGMP ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines études suggèrent un lien entre les dysfonctionnements cGMP et le développement du cancer."
}
},
{
"@type": "Question",
"name": "Les maladies rénales peuvent-elles être influencées par cGMP ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les kinases cGMP jouent un rôle dans la régulation de la fonction rénale."
}
},
{
"@type": "Question",
"name": "Les troubles respiratoires sont-ils liés aux kinases cGMP ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anomalies dans la signalisation cGMP peuvent contribuer à des troubles respiratoires."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour les dysfonctionnements cGMP ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'hypertension, le diabète et le tabagisme."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il la fonction des kinases cGMP ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le vieillissement peut affecter la signalisation cGMP et la santé cardiovasculaire."
}
},
{
"@type": "Question",
"name": "Le mode de vie sédentaire est-il un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire peut augmenter le risque de dysfonctionnement des kinases cGMP."
}
},
{
"@type": "Question",
"name": "Le stress chronique est-il un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut perturber la signalisation cGMP et augmenter les risques de maladies."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux jouent-ils un rôle ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de maladies cardiovasculaires peuvent augmenter le risque."
}
}
]
}
]
}
One major purpose of the IC3D Corneal Dystrophy Nomenclature Revision was to include genetic information with a goal of facilitating investigation into the pathogenesis, treatment, and perhaps even pr...
To date, almost 600 genes have been associated with ocular genetic diseases. As these discoveries are made, clinical genetic testing continues to grow and become a more common element in the diagnosti...
We distributed a REDCap survey to parents of pediatric patients in the Indiana University Ocular Genetics Clinic and through the Foundation Fighting Blindness MyRetinaTracker database to examine facto...
Parents were primarily motivated by the opportunity to learn about their child's prognosis, formal diagnosis, and possible treatment options. Parents were most interested in discussing prognosis, adap...
Parents seem to be generally satisfied by the care from their ocular genetics team. However, families' desires are not being fully met, especially with information about prognosis and support resource...
Isolated frontosphenoidal craniosynostosis (IFSC) is a rare congenital defect defined as premature fusion of the frontosphenoidal suture in the absence of other suture fusion. Until now, IFSC was rega...
Genetic testing has proven utility in identifying and diagnosing individuals with FH. Here we outline the current landscape of genetic testing for FH, recommendations for testing practices and the eff...
Alternatives to the traditional genetic testing and counseling paradigm for FH are being explored including expanding screening programs, testing in primary care and/or cardiology clinics, leveraging ...
Embryo selection in Familial amyloid polyneuropathy eradicates the disease, but the widespread application of preimplantation genetic testing (PGT) for this monogenic disease still requires greater po...
Familial amyloid polyneuropathy is a fatal, chronic, hereditary autosomal dominant neurodegenerative disorder caused by a single nucleotide mutation in the transthyretin gene. The disease courses with...
The application of PGT would prevent the disease, the birth of children with this devastating disease and the enormous health costs associated. For PGT to become the first reproductive option for pati...
The aim of this study is to describe two clinical cases, which we believe highlight the need to consider routine genetic testing of all patients with new diagnosis of a tympanic paraganglioma (PGL)....
Two patients seen in the ENT clinic at a tertiary center with a diagnosis of isolated tympanic PGL, without family history....
Since 2016, all patients with newly diagnosed isolated tympanic PGL (glomus tympanicum) are offered review by the clinical genetic team and genetic testing of a panel of paraganglioma/phaeochromocytom...
We describe the results of genetic testing, the clinical course and discuss the ongoing implications for management....
Both cases were identified to have a pathogenic variant in the SDHB gene after initial surgery. The clinical course for both cases was complicated by disease recurrence, as well as metastatic and secr...
These two cases reinforce the importance of offering genetic testing for all cases of isolated tympanic PGL. The discovery of a significant underlying genetic variant may affect management decisions a...
A significant challenge limiting the comprehensive utilization of genomic medicine is the lack of timely access to genetics specialists. Although neurologists see patients for whom genetic testing sho...
In children undergoing genetic testing for physical health concerns, we examined how often the results also revealed information about their risk for neurodevelopmental disorders. The study sample con...
Alport syndrome is an inherited disorder of the kidneys that results from variants in three collagen IV genes-COL4A3, COL4A4, and COL4A5. Early diagnosis and pharmacologic intervention can delay the p...
Genetic tests have become widely available. We sought to understand the use of genetic tests in the practice of frontline clinicians within the United States Department of Veterans Affairs (VA)....
We administered a web-based survey to clinicians at 20 VA facilities. Physicians, nurse practitioners, physician assistants, and pharmacists were eligible. We excluded genetics providers and clinician...
The response rate was 11.3% (1207/10,680) and of these, 909 respondents were eligible. Only 20.8% of the respondents reported feeling prepared to use genetic tests and 13.0% of the respondents were cu...
Most VA clinicians don't feel prepared to use genetic tests. Those with genetic testing experience are more likely to consult genetics providers. The demand for genetics providers should increase as f...